4.0 Article

Central Nervous System Manifestations of Antiphospholipid Syndrome

Journal

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 43, Issue 4, Pages 547-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2017.06.004

Keywords

Antiphospholipid syndrome (APS); Central nervous system (CNS); Stroke; Chorea; Psychosis; Cognitive disorder; Seizure; Sinus thrombosis

Categories

Ask authors/readers for more resources

Neurologic manifestations are common in patients with antiphospholipid antibodies and include stroke, seizures, dementia, cognitive dysfunction, chorea, migraine, psychosis, and demyelinating disease. Many of these disorders mimic their idiopathic counterparts, but treatment of antiphospholipid antibody-associated disease can be different from the treatment of central nervous system disease not associated with these antibodies. For patients with antiphospholipid antibody-associated neurologic disease, anticoagulation or immunosuppressive therapy or both may significantly improve their symptoms. Thus, clinicians should have a high index of suspicion for antiphospholipid syndrome in the appropriate clinical context.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available